InvestorLens

BCTX — BRIACELL THERAPEUTICS CORP

Public company

Sign in to save1 tracked investor reported this
For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About BRIACELL THERAPEUTICS CORP (BCTX)

BRIACELL THERAPEUTICS CORP (BCTX) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $121,605. Across recent filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in BCTX

100
/100
Strong Institutional Accumulation
Added / Increased1
Reduced0
Exited0
BearishBullish
Crowded Trade Score™

How many top investors track BCTX

7
/100
Undiscovered
1investor

Only 1 tracked investor report this position.

UndiscoveredCrowded
151015+

BCTX Ownership Composition

How BRIACELL THERAPEUTICS CORP is held across tracked investor types, based on reported 13F positions.

Dominant Type
Other
100% of tracked value
Institutions
1
tracked investors
Total Reported
$121.6K
combined 13F value
Sectors1
  • Other100.0%
Other(1)
100.0%

Tracked investors reporting BCTX

  • Ken GriffinSep 30, 2025
    Citadel Advisors
    Shares
    11.1K
    Value
    $121.6K
    % Portfolio
    0.00%

Recent activity

Frequently asked questions

How many institutional investors hold BCTX?
1 tracked institutional investor disclosed a position in BCTX (BRIACELL THERAPEUTICS CORP) in their most recent 13F filing.
Who is the largest institutional holder of BCTX?
Ken Griffin, Citadel Advisors, holds the largest disclosed position in BCTX, valued at $121,605.
Did institutional ownership of BCTX increase or decrease?
Across recent 13F filings, tracked investors recorded 1 new positions, 0 increased, 0 reduced, and 0 fully exited BCTX.
Where does this BCTX ownership data come from?
SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.
BCTX (BRIACELL THERAPEUTICS CORP) — Institutional Holders & — InvestorLens